When and How to Report Biopsy Separately

Why This Topic Matters

Correctly distinguishing when a biopsy is or is not separately reportable affects claim accuracy, compliance, and audit risk. The article is relevant to professionals who code procedures involving lesions, pathology-related decision making, and modifier use.

Article Sections

1. Biopsy reporting and the National Correct Coding Initiative

   Introduces the general issue of when biopsy services are considered separate from other procedures and cites overarching Medicare coding policy guidance.

2. Exception 1

   Describes the first broad circumstance addressed by the article, including separate-lesion reporting considerations and related modifier concepts.

3. Exception 2

   Describes the second broad circumstance addressed by the article, focusing on same-lesion situations tied to pathology-driven procedural decisions.

4. The General Correct Coding Policies provide additional instruction to help clarify biopsy billing

   Summarizes additional policy points about multiple biopsies, specimen handling, and documentation expectations for separate pathologic examination.